Prospective, randomized controlled study to assess the role of dexmedetomidine in patients with supratentorial tumors undergoing craniotomy under general anesthesia

Middle East Journal of Anesthesiology

Volumn 21, Issue 1, 2011, Pages 23-33

  Soliman, Rabie Nasr ^a   Hassan, Amira Refaie ^a   Rashwan, Amr Madih ^a   Omar, Ahmed Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Craniotomy; Dexmedetomidine; Fentanyl intracranial pressure; Neurosurgical intensive care unit; Sevoflurane; Supratentorial tumors

Indexed keywords

ANALGESIC AGENT; DEXMEDETOMIDINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BRAIN TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOTOMY; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL ANESTHESIA; HEART RATE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANESTHESIA, GENERAL; BLOOD PRESSURE; CRANIOTOMY; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SUPRATENTORIAL NEOPLASMS;

EID: 80054834486     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Basali A, Mascha E, Kalfas I, Schubert A: Relation between perioperative hypertension and intracranial hemorrhage after craniotomy. Anesthesiology; 2000, 93:48-54.
2. Kamibayashi T, Maze M: Clinical uses of α 2-adrenergic agonists. Anesthesiology; 2000, 93:1345-1349.
3. Khan ZP, Ferguson CN, Jones RM: α2 and imidazoline receptor agonists: Their pharmacology and therapeutic role. Anaesthesia; 1999, 54:146-165.
4. Chadha R, Padmanabhan V, Joseph A, Mohandas K: Oral clonidine pretreatment for hemodynamic stability during craniotomy. Anaesth Intensive Care; 1992, 20:341-344.
5. Favre JB, Gardaz JP, Ravussin P: Effect of clonidine on ICP and on the hemodynamic responses to nociceptive stimuli in patients with brain tumors. J Neurosurg Anesthesiol; 1995, 7:159-167.
6. Traill R, Gillis R: Clonidine premedication for craniotomy. Effects on blood pressure and thiopentone dosage. J Neurosurg Anesthiol; 1993, 5:171-177.
7. Calzada BC, De Artinano AA: α2-Adrenoreceptor subtypes. Pharmacolog Res; 2001, 44:195-208.
8. Scheinin M, Pihlavisis M: Molecular pharmacology of α2- adrenoreceptor agonists, in Scholz J, Tonner PH (eds): Bailliere's Best Practice and Research: Clinical Anesthesiology α2- Adrenoreceptor Agonists in Anesthesia and Intensive Care. London, Bailliere Tindall, 2000, pp. 247-260.
9. Hodgson PS, Liu SS: New developments in spinal anesthesia. Anesthesiol Clin North America; 2000, 18:235-249.
10. Coursin DB, Coursin DB, Macciolo GA: Dexmedetomidine. Current Opinion in Critical Care; 2001, 7:221-226.
11. Maze M, Scarfini C, Cavaliere F: New agents for sedation in the intensive care unit. Crit Care Clin; 2001, 17:881-897.
12. Bekker AY, Kaufman B, Samir H, Doyle W: The use of dexmedetomidine infusion for awake craniotomy. Anesth Analg; 2001, 92:1251-1253.
13. Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA: Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol; 2004, 16:20-25.
14. Ulrich K, Kuschinsky W: In vivo analysis of alpha-adrenoceptors in pial veins of cats. Acta Physiol Scand Suppl; 1986, 552:37-40.
15. Ma D, Hossain M, Rajakumaraswamy N, Arshad M, Sanders RD, Franks NP, Maze M: Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol; 2004, 502:87-97.
16. McPherson RW, Brian JE, Traystman RJ: Cerebrovascular responsiveness to carbon dioxide in dogs with 1.4% and 2.8% isoflurane. Anesthesiology; 1989, 70:843-50.
17. Hall JE, Uhrich TD, Barney JA, Shahbaz RA, Ebert TJ: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg; 2000, 90:699-705.
18. Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M: Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth; 1992, 68:126-31.
19. Belleville JP, Ward DS, Bloor BC: Effects of intravenous dexmedetomidine in humans. Sedation, ventilation, and metabolic rate. Anesthesiology; 1992, 77:1125-33.
20. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K: Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth Analg; 1992, 75:940-6.
21. Aantaa R, Jaakola ML, Kallio A, Kanto J: Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology; 1997, 86:1055-60.
22. Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D: Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth; 1999, 83:372-80.
23. Chadha R, Padmanabhan V, Joseph A, Mohandas K. Oral clonidine pretreatment for haemodynamic stability during craniotomy. Anaesth Intensive Care; 1992, 20:341-4.
24. Costello TG, Cormack JR: Clonidine premedication decreases hemodynamic responses to pin head-holder application during craniotomy. Anesth Analg; 1998, 86:1001-4.
25. Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M: Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth; 1992, 68:126-31.
26. Aho M, Erkola O, Kallio A, Scheinin H, Korttila K: Dexmedetomidine infusion for maintenance of anesthesia in patients undergoing abdominal hysterectomy. Anesth Analg; 1992, 75:940-6.
27. Lawrence CJ, De Lange S: Effects of a single preoperative dexmedetomidine dose on isoflurane requirements and perioperative haemodynamic stability. Anaesthesia; 1997, 52:736-44.
28. Lawrence CJ, De Lange S: Effects of a single preoperative dexmedetomidine dose on isoflurane requirements and perioperative haemodynamic stability. Anaesthesia; 1997, 52:736-44.
29. Talke P, Chen R, Thomas B, et al: The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg; 2000, 90:834-9.
30. Takenaka M, Iida H, Iida M, Dohi S: Intrathecal dexmedetomidine attenuates hypercapnic but not hypoxic cerebral vasodilation in anesthetized rabbits. Anesthesiology; 2000, 92:1376-84.
31. Ulrich K, Kuschinsky W: In vivo effects of α2-adrenoreceptor agonists and antagonists on pial veins of cats. Stroke; 1985, 16:880-84.
32. Hsu YW, Cortinez LI, Robertson KM, et al: Dexmedetomidine pharmacodynamics: Part 1: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology; 2004, 101:1066-76.
33. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology; 2000, 93:382-94.
34. Hall JE, Uhrich TD, Barney JA, Shahbaz RA, Ebert TJ: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg; 2000, 90:699-705.
35. Shehabi Y, Ruettimann U, Adamson H, Innes R, Ickeringill M: Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects. Intensive Care Med; 2004, 30:2188-96.
36. Arain SR, Ruehlow RM, Uhrich TD, Ebert TJ: The efficacy of dexmedetomidine versus morphine for postoperative nalgesia after major inpatient surgery. Anesth Analg; 2004, 98:153-158.
37. Venn RM, Bradshaw CJ, Spencer R, Brealey D, Caudwell E, Naughton C, Vedio A, Singer M, Feneck R, Treacher D, Willatts SM, Grounds RM: Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia; 1999, 54:1136-1142.
38. Scott F Thomas Hebert, Randy Cook, Pamela K McPherson, R Jack Cassingham: Intraoperative Dexmedetomidine Administration Reduces Postoperative Nausea and Vomiting. American Society Of Anesthesiologists; October 2007, 13-17.
39. Xu H, Aibiki M, Seki K, Ogura S, Ogli K: Effects of dexmedetomidine, an α2-adrenoceptor agonist, on renal sympathetic nerve activity, blood pressure, heart rate and central venous pressure in urethane-anesthetized rabbits. J Auton Nerv Syst; 1998, 72:48-54.
40. Gellai M: Modulation of vasopressin antidiuretic action by renal α2-receptors. Am J Physiol; 1990, 259:F1-F8.
41. Menegaz RG, Kapusta DR, Mauad H, de Melo Cabral A: Activation of α2-adrenoreceptors in the rostral ventrolateral medulla evokes natriuresis by arenal nerve mechanism. Am J Physiol; 2001, 218:R98-R101.